UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Highly flexible, wearable, and disposable cardiac biosensors for remote and ambulatory monitoring

NPJ digital medicine, 2018-01, Vol.1 (1), p.2-2, Article 2

2018

Volltextzugriff (PDF)

Digitizing Medicines for Remote Capture of Oral Medication Adherence Using Co‐encapsulation

Clinical pharmacology and therapeutics, 2018-03, Vol.103 (3), p.502-510

2018

Volltextzugriff (PDF)

The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response

AIDS (London), 1999-06, Vol.13 (9), p.1099-1107

1999

Volltextzugriff (PDF)

The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women

Clinical endocrinology (Oxford), 1998-10, Vol.49 (4), p.421-432

1998

Volltextzugriff (PDF)

Pooling Strategies to Reduce the Cost of HIV-1 RNA Load Monitoring in a Resource-Limited Setting

Clinical infectious diseases, 2011-01, Vol.52 (2), p.264-270

2011

Volltextzugriff (PDF)

Efficacy and safety of ledipasvir/sofosbuvir, with or without ribavirin, for treatment of hepatitis C virus-mono and HCV/HIV co-infected patients who have failed prior treatment with non-NS5A, SOF-based therapies

Journal of hepatology, 2017, Vol.66 (1), p.S307-S307

2017

Volltextzugriff (PDF)

Community HIV‐1 drug resistance is associated with transmitted drug resistance

HIV medicine, 2014-07, Vol.15 (6), p.339-346

2014

Volltextzugriff (PDF)

Differential escape patterns within the dominant HLA-B57:03-restricted HIV Gag epitope reflect distinct clade-specific functional constraints

Journal of virology, 2014-05, Vol.88 (9), p.4668-4678

2014

Volltextzugriff (PDF)

Ion PGM deep sequencing improves mutation detection in infants who failed PMTCT

International journal of infectious diseases, 2014-04, Vol.21 (S1), p.131-132

2014

Volltextzugriff (PDF)

A Trial Comparing Nucleoside Monotherapy with Combination Therapy in HIV-Infected Adults with CD4 Cell Counts from 200 to 500 per Cubic Millimeter

The New England journal of medicine, 1996-10, Vol.335 (15), p.1081-1090

1996

Volltextzugriff (PDF)

Clinical Utility of Resistance Testing: Retrospective and Prospective Data Supporting Use and Current Recommendations

Journal of acquired immune deficiency syndromes (1999), 2001-03, Vol.26, p.S51-S59

2001

Volltextzugriff (PDF)

Identification of Patients with Acute AIDS-Associated Cryptococcal Meningitis Who Can Be Effectively Treated with Fluconazole: The Role of Antifungal Susceptibility Testing

Clinical infectious diseases, 1996-02, Vol.22 (2), p.322-328

1996

Volltextzugriff (PDF)

Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment

AIDS (London), 2009-06, Vol.23 (9), p.1109-1118

2009

Volltextzugriff (PDF)

Phenotypic and Genotypic Resistance Assays: Methodology, Reliability, and Interpretations

Journal of acquired immune deficiency syndromes (1999), 2001-03, Vol.26, p.S3-S9

2001

Volltextzugriff (PDF)

Greater Tenofovir-Associated Renal Function Decline with Protease Inhibitor-Based versus Nonnucleoside Reverse-Transcriptase Inhibitor-Based Therapy

The Journal of infectious diseases, 2008-01, Vol.197 (1), p.102-108

2008

Volltextzugriff (PDF)

Efficacy and safety of etravirine in treatment-experienced, HIV-1 patients: pooled 48 week analysis of two randomized, controlled trials

AIDS (London), 2009-11, Vol.23 (17), p.2289-2300

2009

Volltextzugriff (PDF)

Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials

The Lancet (British edition), 2007-04, Vol.369 (9568), p.1169-1178

2007

Volltextzugriff (PDF)

Low Baseline CD4+Count Is Associated With Greater Bone Mineral Density Loss After Antiretroviral Therapy Initiation

Clinical infectious diseases, 2013-11, Vol.57 (10), p.1483-1488

2013

Volltextzugriff (PDF)

Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study

The Journal of infectious diseases, 2014-08, Vol.210 (3), p.354-362

2014

Volltextzugriff (PDF)

POSB13 Thirty-Day Readmission in US Hospitalized COVID-19 Patients

Value in health, 2022-01, Vol.25 (1), p.S27-S27

2022

Volltextzugriff (PDF)

PIN82 Real-World Utilization of Remdesivir in 2020: A Retrospective Cohort Study

Value in health, 2021-06, Vol.24, p.S121-S121

2021

Volltextzugriff (PDF)

Cohort profile: the Centers for AIDS Research Network of Integrated Clinical Systems

International journal of epidemiology, 2008-10, Vol.37 (5), p.948-955

2008

Volltextzugriff (PDF)

The clinical relevance of non-nucleoside reverse transcriptase inhibitor hypersusceptibility: a prospective cohort analysis

AIDS (London), 2002-10, Vol.16 (15), p.F33-F40

2002

Volltextzugriff (PDF)

POSB12 Association Between Remdesivir Treatment and In-Hospital All-Cause Mortality Among Patients Hospitalized with COVID-19

Value in health, 2022-01, Vol.25 (1), p.S27-S27

2022

Volltextzugriff (PDF)

Clinical Outcomes in Persons Coinfected With Human Immunodeficiency Virus and Hepatitis C Virus: Impact of Hepatitis C Virus Treatment

Clinical infectious diseases, 2020-05, Vol.70 (10), p.2131-2140

2020

Volltextzugriff (PDF)

1 – 25 von 553

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(451)
Mit Volltextzugriff
(369)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(475)
Deutsch
(80)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Highly flexible, wearable, and disposable cardiac biosensors for remote and ambulatory monitoring

Digitizing Medicines for Remote Capture of Oral Medication Adherence Using Co‐encapsulation

The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response

The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women

Pooling Strategies to Reduce the Cost of HIV-1 RNA Load Monitoring in a Resource-Limited Setting

Efficacy and safety of ledipasvir/sofosbuvir, with or without ribavirin, for treatment of hepatitis C virus-mono and HCV/HIV co-infected patients who have failed prior treatment with non-NS5A, SOF-based therapies

Community HIV‐1 drug resistance is associated with transmitted drug resistance

Differential escape patterns within the dominant HLA-B57:03-restricted HIV Gag epitope reflect distinct clade-specific functional constraints

Ion PGM deep sequencing improves mutation detection in infants who failed PMTCT

A Trial Comparing Nucleoside Monotherapy with Combination Therapy in HIV-Infected Adults with CD4 Cell Counts from 200 to 500 per Cubic Millimeter

Clinical Utility of Resistance Testing: Retrospective and Prospective Data Supporting Use and Current Recommendations

Identification of Patients with Acute AIDS-Associated Cryptococcal Meningitis Who Can Be Effectively Treated with Fluconazole: The Role of Antifungal Susceptibility Testing

Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment

Phenotypic and Genotypic Resistance Assays: Methodology, Reliability, and Interpretations

Greater Tenofovir-Associated Renal Function Decline with Protease Inhibitor-Based versus Nonnucleoside Reverse-Transcriptase Inhibitor-Based Therapy

Efficacy and safety of etravirine in treatment-experienced, HIV-1 patients: pooled 48 week analysis of two randomized, controlled trials

Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials

Low Baseline CD4+Count Is Associated With Greater Bone Mineral Density Loss After Antiretroviral Therapy Initiation

Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study

POSB13 Thirty-Day Readmission in US Hospitalized COVID-19 Patients

PIN82 Real-World Utilization of Remdesivir in 2020: A Retrospective Cohort Study

Cohort profile: the Centers for AIDS Research Network of Integrated Clinical Systems

The clinical relevance of non-nucleoside reverse transcriptase inhibitor hypersusceptibility: a prospective cohort analysis

POSB12 Association Between Remdesivir Treatment and In-Hospital All-Cause Mortality Among Patients Hospitalized with COVID-19

Clinical Outcomes in Persons Coinfected With Human Immunodeficiency Virus and Hepatitis C Virus: Impact of Hepatitis C Virus Treatment

Suchergebnisse filtern